Aligned with India’s vision of becoming a global pharma innovation hub, ‘India Pharma 2026’ seeks to shift the sector from a volume-driven to an innovation-led model. The 9th edition of India Pharma 2026, organized by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers in collaboration with FICCI and the Indian Pharmaceutical Alliance (IPA), is scheduled for April 13-14 in New Delhi. The event will be inaugurated by JP Nadda, Minister of Chemicals and Fertilizers, and Anupriya Patel, Union Minister of State for Chemicals and Fertilizers.
The conference aims to foster sectoral growth and global collaboration, emphasizing India’s pharmaceutical capabilities, research and development (R&D), and the resilience of global supply chains. With the theme ‘Discover in India: Leapfrogging Life-Sciences Innovation,’ the event underscores the transformative impact of life sciences on healthcare access, economic growth, and global health systems.
India’s significant role in supplying affordable, high-quality medicines globally forms the foundation for India Pharma 2026. The event intends to propel the sector towards a value- and innovation-driven approach. Noteworthy attendees include policymakers, industry leaders, and experts like Manoj Joshi, Secretary, Department of Pharmaceuticals; Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare; and Prof. Vinod K. Paul, Member, NITI Aayog.
The event will also host domain experts such as Dr. Renu Swarup, Former Secretary, Department of Biotechnology, and Dr. Shivkumar Kalyanaraman, CEO, Anusandhan National Research Foundation (ANRF). Alongside a ‘Start-up Showcase’ session, the two-day event will feature six plenary sessions.
